Literature DB >> 22493760

Oncologic manifestations of neurofibromatosis type 1 in Korea.

Eui Tae Kim1, Hwan Namgung, Hyun Deok Shin, Soon Il Lee, Jee Eun Kwon, Myung Chul Chang, Dong Guk Park.   

Abstract

PURPOSE: The aim of this study was to investigate the incidence and spectrum of malignant tumors in Korean neurofibromatosis type 1 (NF1) patients.
METHODS: We retrospectively reviewed 125 patients who were diagnosed with NF1 at a single institution from 1995 to 2010. The incidence, location, histologic type, and radiologic findings of malignant tumors as well as development of multiple primary tumors were analyzed.
RESULTS: Eighteen malignant tumors occurred in 16 patients (12.8%) among 125 Korean NF1 patients; 9 carcinomas, 8 sarcomas and 1 central nervous system (CNS) tumor. Five tumors were of nervous system origin and 13 were non-nervous system tumors. The locations of the tumors were as follow: 1 CNS, 2 lung, 3 breast, 3 stomach, 3 small bowel, 1 colon, 1 liver, 1 uterus, 1 neck, and 2 in extremities. Three malignant peripheral nerve sheath tumors (MPNSTs) occurred at the neck and extremity, and one in the liver. All three gastrointestinal stromal tumors (GISTs) had multiple tumors in the jejunum, and one MPNST and one pheochromocytoma were accompanied in two GISTs. Multiple primary tumors, benign or malignant were reported in 4 patients (25.0%), synchronously or metachronously.
CONCLUSION: Korean NF1 patients had a high risk of developing malignant tumors. The common malignant tumors in Koreans such as breast, lung and stomach cancers developed frequently in addition to the NF1-related tumors such as MPNST or GIST.

Entities:  

Keywords:  Korea; Malignant neoplasms; Neurofibromatosis 1

Year:  2012        PMID: 22493760      PMCID: PMC3319773          DOI: 10.4174/jkss.2012.82.4.205

Source DB:  PubMed          Journal:  J Korean Surg Soc        ISSN: 1226-0053


  9 in total

1.  Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients.

Authors:  Dae Young Kang; Cheol Keun Park; Jong Sang Choi; So Young Jin; Hyun Jung Kim; Mee Joo; Mi Seon Kang; Woo Sung Moon; Ki Jung Yun; Eun Sil Yu; Haeyun Kang; Kyoung-Mee Kim
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

2.  Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.

Authors:  M E Zöller; B Rembeck; A Odén; M Samuelsson; L Angervall
Journal:  Cancer       Date:  1997-06-01       Impact factor: 6.860

3.  Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms.

Authors:  S A Sørensen; J J Mulvihill; A Nielsen
Journal:  N Engl J Med       Date:  1986-04-17       Impact factor: 91.245

4.  Gastrointestinal stromal tumor with KIT mutation in neurofibromatosis type 1.

Authors:  Hwan Namgung
Journal:  J Korean Surg Soc       Date:  2011-10-28

5.  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.

Authors: 
Journal:  Arch Neurol       Date:  1988-05

6.  Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases.

Authors:  Markku Miettinen; John F Fetsch; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2006-01       Impact factor: 6.394

Review 7.  Malignancy in neurofibromatosis type 1.

Authors:  B R Korf
Journal:  Oncologist       Date:  2000

Review 8.  Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1.

Authors:  Hilde Brems; Eline Beert; Thomy de Ravel; Eric Legius
Journal:  Lancet Oncol       Date:  2009-05       Impact factor: 41.316

Review 9.  Clinical and genetic aspects of neurofibromatosis 1.

Authors:  Kimberly Jett; Jan M Friedman
Journal:  Genet Med       Date:  2010-01       Impact factor: 8.822

  9 in total
  8 in total

1.  Multiple gastrointestinal stromal tumors and pheochromocytoma in a patient with von Recklinghausen's disease.

Authors:  Beyza Ozcinar; Nihat Aksakal; Orhan Agcaoglu; Mustafa Tukenmez; Ibrahim A Ozemir; Umut Barbaros; Nese Colak; Yesim Erbil
Journal:  Int J Surg Case Rep       Date:  2012-11-23

2.  Rectal carcinoma and multiple gastrointestinal stromal tumors (GIST) of the small intestine in a patient with neurofibromatosis type 1: a case report.

Authors:  Yuhei Hakozaki; Shinichi Sameshima; Teppei Tatsuoka; Takashi Okuyama; Yukinori Yamagata; Tamaki Noie; Masatoshi Oya; Akiko Fujii; Yoshihiko Ueda; Chieko Shimura; Kazumoto Katagiri
Journal:  World J Surg Oncol       Date:  2017-08-23       Impact factor: 2.754

3.  Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature.

Authors:  Lorena P Suarez-Kelly; Lianbo Yu; David Kline; Eric B Schneider; Doreen M Agnese; William E Carson
Journal:  Hered Cancer Clin Pract       Date:  2019-03-25       Impact factor: 2.857

4.  Case report of ascending colon cancer and multiple jejunal GISTs in a patient with neurofibromatosis type 1 (NF1).

Authors:  Liang Shang; Zhen Fang; Jin Liu; Fengying Du; Haiyan Jing; Yali Xu; Kangdi Dong; Xiaoman Zhang; Hao Wu; Changqing Jing; Leping Li
Journal:  BMC Cancer       Date:  2019-12-05       Impact factor: 4.430

Review 5.  A genetic model for gallbladder carcinogenesis and its dissemination.

Authors:  S G Barreto; A Dutt; A Chaudhary
Journal:  Ann Oncol       Date:  2014-04-04       Impact factor: 32.976

6.  Rapid diagnosis of combined multifocal gastrointestinal stromal tumours and coeliac disease in a patient with type 1 neurofibromatosis.

Authors:  Mary Hussey; Grainne Holleran; Deirdre McNamara
Journal:  JRSM Short Rep       Date:  2013-07-01

7.  A long-term survival case of a primary malignant intracerebral nerve sheath tumor.

Authors:  Byung Sun Lee; Young Gyu Kim; Dong Ho Kim; Mou Seop Lee
Journal:  J Korean Neurosurg Soc       Date:  2013-09-30

8.  Synchronous neuroendocrine tumor and non-small-cell lung cancer in neurofibromatosis type 1.

Authors:  Andrew Hsu; Samuel Han
Journal:  Clin Case Rep       Date:  2015-11-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.